ZytoMax is now the exclusive distributor of AmoyDx® products in Switzerland
We are delighted to inform you that due to the positive customer response, the molecular diagnostic products of our partner AmoyDx® are now available to our customers in Switzerland through ZytoMax Schweiz GmbH, a sister company of Zytomed Systems GmbH.
AmoyDx® is a research and development-based diagnostics company with over 1000 employees that focuses on molecular diagnostics for oncological precision medicine. The primarily CE/IVD labeled qPCR and NGS products have proven to be of excellent quality and reliability, as confirmed by numerous successful external proficiency tests conducted by our customers. Furthermore, our product and laboratory team are happy to offer advice and active support during the introduction and establishment of the products.
If you are interested, please do not hesitate to contact your local contact at ZytoMax Schweiz GmbH, via e-mail at info@zytomax.ch or phone at +41 79 965 68 67.
Further topics
Experts to Experts Program
Workshops & Webinars 2024
Product update: BRCA1 and BRCA2
The new AmoyDx® BRCA Pro Panel is an improved version of the AmoyDx® BRCA1 and BRCA2 Gene Mutation Detection Kit. Both kits enable analysis of the entire coding regions of the BRCA1 and BRCA2 genes, and of exon/ intron boundries in DNA from FFPE specimen and from peripheral whole blood.
